Health Care & Life Sciences » Medical Equipment & Supplies | NeuroMetrix Inc.

NeuroMetrix Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,278.80
5,512.80
7,299.80
12,027.50
17,092.30
16,090.10
Cost of Goods Sold (COGS) incl. D&A
2,194.30
2,568.60
3,950.70
7,113.00
10,235.50
8,707.10
Gross Income
3,084.50
2,944.20
3,349.10
4,914.50
6,856.80
7,383.10
SG&A Expense
10,443.40
11,714.20
16,625.30
20,122.50
19,939.40
19,674.60
EBIT
7,358.80
8,770.10
-
15,208.00
13,082.60
12,291.60
Unusual Expense
289.70
1,050.10
4,083.60
275.70
208.50
-
Non Operating Income/Expense
376.30
50.90
-
-
-
12,315.20
Pretax Income
8,019.10
7,766.20
9,187.30
14,913.20
12,859.30
23.60
Consolidated Net Income
8,019.10
7,766.20
8,597.60
14,913.20
12,859.30
23.60
Net Income
8,019.10
7,766.20
8,597.60
14,913.20
12,859.30
23.60
Net Income After Extraordinaries
8,019.10
7,766.20
8,597.60
14,913.20
12,859.30
23.60
Net Income Available to Common
8,786.00
10,721.90
21,070.30
34,759.50
19,734.00
23.60
EPS (Basic)
98.23
49.28
62.00
58.24
11.60
-
Basic Shares Outstanding
89.40
217.90
339.90
597.10
1,701.50
7,104.60
EPS (Diluted)
98.23
49.20
61.99
58.21
11.60
-
Diluted Shares Outstanding
89.40
217.90
339.90
597.10
1,701.50
13,885.60
EBITDA
7,208.20
8,625.00
13,053.60
14,956.60
12,820.30
12,121.90
Non-Operating Interest Income
5.70
4.60
5.20
19.10
14.90
-
Other After Tax Income (Expense)
-
-
589.80
-
-
-
Preferred Dividends
766.90
2,955.70
12,472.70
19,846.40
6,874.80
-

About NeuroMetrix

View Profile
Address
1000 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.neurometrix.com
Updated 07/08/2019
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.